ctrl K

Price Alert

Emergent BioSolutions Inc... (EBS)

NYSE: EBS · Real-Time Price · USD

8.85

0.03 (0.34%)

At close: Aug 15, 2025, 3:59 PM

8.82

-0.28%

After-hours: Aug 15, 2025, 07:40 PM EDT

Emergent BioSolutions Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	99.5M	111.7M	642.6M	576.1M
Short-Term Investments	n/a	n/a	8.5M	n/a
Long-Term Investments	n/a	n/a	n/a	n/a
Other Long-Term Assets	18.9M	178.1M	191.3M	57.3M
Receivables	154.5M	191M	159.2M	278.9M
Inventory	311.7M	328.9M	351.8M	350.8M
Other Current Assets	33M	47.9M	57.9M	100K
Total Current Assets	598.7M	679.5M	1.21B	1.27B
Property-Plant & Equipment	270.6M	399M	817.6M	800.1M
Goodwill & Intangibles	501.5M	566.6M	947M	829.5M
Total Long-Term Assets	791M	1.14B	1.96B	1.69B
Total Assets	1.39B	1.82B	3.17B	2.96B
Account Payables	60.9M	112.2M	103.5M	128.9M
Deferred Revenue	n/a	n/a	26.4M	140.4M
Short-Term Debt	n/a	413.7M	957.3M	31.6M
Other Current Liabilities	83.8M	106.8M	133.2M	161.8M
Total Current Liabilities	162.4M	651.3M	1.23B	373.8M
Long-Term Debt	663.7M	446.5M	448.5M	809.4M
Other Long-Term Liabilities	39.1M	76.1M	26.7M	40.6M
Total Long-Term Liabilities	744.5M	522.6M	553.7M	966.2M
Total Liabilities	906.9M	1.17B	1.78B	1.34B
Total Debt	663.7M	860.2M	1.41B	841M
Common Stock	100K	100K	100K	100K
Retained Earnings	-212.4M	-21.8M	734M	957.8M
Comprehensive Income	-5.2M	-5.7M	3.1M	-16.1M
Shareholders Equity	482.8M	649.3M	1.38B	1.62B
Total Investments	n/a	n/a	8.5M	n/a